// App-Quantinova.ai

2655 : Oncogenic chromatin factors drive cell type-specific transcription within megadomains in NUT midline carcinoma

Researchers

Presenter

  • Mitzi I. Kuroda

Principal Investigators

  • Artyom A. Alekseyenko

  • Erica M. Walsh

  • Xin Wang

  • Adlai Grayson

  • Peter T. Hsi

  • Peter V. Kharchenko

  • Christopher A. French

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • NUT midline carcinoma

  • Squamous cell carcinoma

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

  • cMYC

  • CREB-binding protein

  • E1A Binding Protein P300

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved